New devices could revolutionize cervical cancer screening in africa

NCT ID NCT05372484

Recruiting now Diagnosis Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This study in Mozambique is testing two new technologies to improve cervical cancer screening and diagnosis. Researchers will compare a rapid HPV test and a special imaging device against standard methods in about 678 women. The goal is to find faster, more accurate ways to detect cervical cancer, especially in areas with limited resources.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to more accurate and accessible screening tools for cervical cancer in low-resource settings.
What could go wrong: This is an early-stage diagnostic study, not a treatment trial. The new technologies may not prove more accurate than current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER

Contacts and locations

Locations

José Macamo General Hospital and Health Center
RECRUITING

Maputo, 1106, Mozambique
M D Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
Maputo Central Hospital
RECRUITING

Maputo, 1106, Mozambique
Mavalane Hospital and Health Center
RECRUITING

Maputo, 1108, Mozambique

More trials for these conditions

Other studies related to the condition(s) this trial covers.